Last reviewed · How we verify
NCT03292744
Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly
Phase 4 trial testing Alfacalcidol in Frail Elderly Syndrome in 110 participants. Status unknown.
10 October 2017
Quick facts
| Lead sponsor | Indonesia University |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 110 |
| Start date | 10 January 2017 |
| Primary completion | 10 October 2017 |
| Estimated completion | 15 December 2017 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Alfacalcidol (ALFACALCIDOL) — full drug profile →
Conditions studied
- Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →
- Elderly Infection — all drugs for Elderly Infection →
Sponsor
Indonesia University
Who can join
60 and older, any sex, with Frail Elderly Syndrome or Elderly Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Vitamin D has been known to influence immune response through Vitamin D Receptor in Immune Cells, but only few has been known about the effect alfacalcidol, a vitamin D analog to immune system. In elderly, immune disregulation or immunosenecence have great impact to infection response. This study is aimed to determine the effect of alfacalcidol supplementation in vitro and in vivo to respiratory infection incidence and inflammatory markers, as well as T cell lymphocyte subset in Indonesian elderly patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03292744
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alfacalcidol
Trials testing the same drug.
- NCT03210688 — Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy · Phase 4 · completed
- NCT02824718 — Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism · Phase 2 · completed
- NCT03147677 — Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan · Phase 4 · completed
Other recruiting trials for Frail Elderly Syndrome
Currently open trials in the same condition.
- NCT06857981 — Patient's Database: Prepare for Your Surgery Program · recruiting
- NCT06469437 — The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM · NA · recruiting
- NCT06444321 — INTEgRated Health CARE for Patients With Frailty and Heart Failure · NA · recruiting
- NCT05993754 — Non-pharmacological Prevention of POD in Frailty Elderly Undergoing Elective Surgery Applied by Nursing Teams · NA · recruiting
- NCT06496022 — Comparative Analysis of Risk Factors and Prediction of Frailty Syndrome · active not recruiting
Other Indonesia University trials
Trials by the same sponsor.
- NCT07137130 — Secretome TGF Beta 3 · NA · not yet recruiting
- NCT07420335 — Preoperative Shoulder Exercises and Postoperative Inflammation, Pain, and Function After Modified Radical Mastectomy · NA · not yet recruiting
- NCT07278284 — The Effectiveness of Press Needle Acupuncture on Preoperative Anxiety in Tympanoplasty and Mastoidectomy · NA · recruiting
- NCT07337187 — Effect of Thread-Embedding Acupuncture at EX-B2 on Pain and Quality of Life in Chronic Low Back Pain · NA · not yet recruiting
- NCT07242001 — Laser Acupuncture for Otitis Media With Effusion in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03292744 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indonesia University
- Last refreshed: 26 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292744.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing